EGY Q1 2026 Earnings Significant EPS Miss Amid Challenging Quarter PDD Q4 2025 Earnings EPS Misses Estimates by Wide Margin Stock Declines GT Q1 2026 Earnings NarrowerThanExpected Loss Boosts Investor Sentiment WIT Q1 2026 Earnings EPS Misses Estimates Amid Modest Stock Gain Cannae Holdings Q1 2026 Earnings Wide EPS Miss as Investment Losses Bite Aytu BioPharma Gains 164 as Stock Tests Key Resistance at 228 YD Bio Warrants Dip 6 as Support Level Approaches American Financial Group Subordinated Debentures AFGD Hold Steady Near 1986 Amid Low Volatility Kymera Therapeutics KYMR Shows Modest Upside as Biotech Sector Stabilizes MSGE Q1 2026 Earnings EPS Misses Estimates Despite Modest Stock Gain